Skip to content

Acute Alcohol Response In Bipolar Disorder: a fMRI Study

Subjective Response to Alcohol and Associated Neural Systems in Bipolar Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04063384
Acronym
BACS
Enrollment
60
Registered
2019-08-21
Start date
2019-07-22
Completion date
2024-03-31
Last updated
2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Alcohol Drinking, Alcohol Use Disorder

Brief summary

Alcohol use disorders (AUDs) affect up to 60% of individuals with bipolar disorder during their lifetime-a rate 3 to 5 times higher than what occurs in the general population. The mechanisms that contribute to elevated rates of comorbidity are not known. Early identification in individuals with bipolar disorder who are at risk for AUDs could inform novel intervention strategies and improve life-long outcomes. The primary objective of this protocol is to use alcohol administration procedures and functional MRI techniques to investigate subjective response to alcohol, compared to placebo, and relationship with functional responses of, and connectivity among, brain regions in ventral prefrontal emotional networks in young adults with bipolar disorder and healthy comparison young adults. Baseline clinical and structural MRI assessments will be completed in 30 bipolar and 30 healthy young adults (21-26 years of age, 50% women). Then, following standard beverage administration procedures, participants will complete within-person, counter-balanced, fMRI scans and complete measures of subjective response to alcohol while under the influence of alcohol or placebo. Specifically, individual differences in the experience of stimulating, sedative, and anxiolytic effects of alcohol (measured with self-report surveys) and individual differences in neural responses to alcohol within ventral prefrontal emotional networks will be investigated and differences in bipolar disorder compared to healthy participants assessed. Functional MRI scans during a continuous performance task with emotional and neutral distractors (CPT-END) and at rest will be collected while under the influence of alcohol and placebo and compared. Experience of stimulating, sedative, and anxiolytic effects of alcohol from self-report survey data and neural responses to emotional stimuli while under the influence of alcohol compared to placebo will be the primary data outcomes assessed. Additionally, associations between subjective and neural response to alcohol and drinking patterns will be explored (secondary outcomes). The primary endpoint of the study will be after completion of both alcohol and placebo beverage conditions.

Detailed description

A total of 60 bipolar and healthy comparison subjects (n=30 per group, 21-26 years of age, 50% women, with no history of a moderate/severe AUD) will be recruited from the greater Austin area. Once recruited and enrolled, subjects will undergo detailed structured clinical evaluations to verify inclusion and exclusion criteria, comprehensive assessment of alcohol and other drug use history, and cognitive testing, followed by structural MRI assessments. Following standard beverage administration procedures, they will then complete measures of subjective response to alcohol and fMRI scans while under the influence of alcohol or a placebo condition (counter-balanced). For each participant the first beverage session assignment (whether the participant is given alcohol or the placebo beverage first) will be randomized. Alcohol and placebo sessions will occur within 3 days of each other. FMRI assessments will include a continuous performance task with emotional and neutral distractors (CPT-END) and a resting state scan. For both the alcohol and the placebo beverage conditions, the protocol will be the same. The beverage administration sessions will occur in a private room at the University of Texas at Austin in the Imaging Research Center. The table in the testing room will be wiped down with alcohol prior to the participant's arrival (olfactory cue). Study staff will use an algorithm to calculate individual alcohol doses based on the participants' age, sex, height, and weight. Participants fast from food for 4 hours prior to their session. Before beginning consumption of their beverages, they will eat a weight-adjusted, 1 calorie per pound snack of pretzels. While participants eat their pretzels, study staff will mix beverages in front of participants. Vodka and placebo (decarbonated tonic water) will be stored in absolute vodka bottles, measured out, and combined with mixer in front of participants. Mixed drinks will be poured into glasses that have been sitting face down with rims soaking in vodka. Prior to giving the beverage to the participant, all drinks will get an alcohol floater (squirt of absolute vodka on top of the drink). Participants will be given 20 minutes to orally consume two beverages (10 minutes per beverage). Following oral consumption and a 10 minute absorption period, breathalyzer tests will be conducted to identify a .06g% ascending limb breath alcohol concentration (BrAC). Self-report of subjective response to alcohol will be collected and participants will immediately enter the scanner and complete the fMRI scan (acquisition parameters are identical during alcohol and placebo conditions). BrAC will be tracked after the MRI scan and subjective response to alcohol collected again at peak BrAC and at descending BrAC of .06g%. Consistent with NIAAA guidelines for human alcohol studies, BrAC readings will continue every 30 minutes until participants are below 0.04% at which time they will be escorted home. During the placebo condition, participants will be given false BrAC readings. False BrAC readings given to participants during the placebo session will be based on the average BrACs we record during the alcohol sessions. The average time participants stay in the laboratory will be the same for the placebo and alcohol beverage conditions. Participants are debriefed after completing all sessions and the need for deception to ensure the placebo-controlled alcohol session will be explained.

Interventions

Participants will be provided alcohol during study visits and changes in behavior/neural activity after consuming alcohol will be examined.

OTHERPlacebo beverage

placebo beverage conditions.

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 26 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion criteria for all participants: * between 21 and 26 years of age * having consumed at least 4 (men) or 3 (women) drinks on a single occasion over the last year * euthymic at the time of study Inclusion criteria for bipolar disorder participants: \- Meeting Diagnostic and Statistical Manual-5 Research Version (DSM-V-RV) diagnostic criteria for bipolar disorder, confirmed by structured interview

Exclusion criteria

For all subjects

Design outcomes

Primary

MeasureTime frameDescription
Level of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)up to 1 weekParticipants fill out self-report surveys \[specifically the Subjective Effects of Alcohol Scale (SEAS)\] on how they feel when they arrive to their beverage administration sessions (alcohol and placebo sessions). They then feel out the same self-report surveys on how intoxicated they feel during their beverage sessions (alcohol and placebo). Changes in how intoxicated they feel is calculated for both the alcohol and placebo condition (compared to how they felt pre-beverage). 4 subscores are calculated by summing individual items: positive valence/positive arousal (stimulation), SEAS positive valence/negative arousal (anxiolytic), negative valence/negative arousal (aggression/agitation), and negative valence/negative arousal (sedative effects). Summed subscores on the SEAS range between 0 and 40. Change scores can therefore range between -40 and 40 (post-beverage compared to pre-beverage feelings). Scores greater than 0 on any one subscale indicates feeling more effects of alcohol.
Change in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)up to 1 weekNeural responses to emotional stimuli during the alcohol and placebo sessions were modeled. Fisher transformed correlation coefficients between regions of interest while viewing emotional stimuli (compared to squares) were calculated for each beverage session and data extracted for posthoc analysis. Values represent change scores in correlation coefficients during each beverage session.

Countries

United States

Participant flow

Recruitment details

60 participants were recruited.

Pre-assignment details

Participants were randomly assigned to receiving placebo first or alcohol beverage session first.

Participants by arm

ArmCount
BD Alcohol First, Then Placebo
Participants will be dosed to a 0.08g% blood alcohol concentration on alcohol day and then on a following day was dosed to \<.01 blood alcohol concentration (placebo day).
15
TD Alcohol First, Then Placebo
Participants will be dosed to a 0.08g% blood alcohol concentration on alcohol day and then on a following day was dosed to \<.01 blood alcohol concentration (placebo day).
13
BD Placebo First, Then Alcohol
Participants were dosed to \<.01 blood alcohol concentration (placebo day) for their first beverage, and then on a following day were dosed to a 0.08g% blood alcohol concentration (alcohol day).
13
TD Placebo First, Then Alcohol
Participants were dosed to \<.01 blood alcohol concentration (placebo day) for their first beverage, and then on a following day were dosed to a 0.08g% blood alcohol concentration (alcohol day).
13
Total54

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall Studyplacebo manipulation issue1211

Baseline characteristics

CharacteristicBD Alcohol First, Then PlaceboTD Alcohol First, Then PlaceboBD Placebo First, Then AlcoholTD Placebo First, Then AlcoholTotal
Age, Continuous23.3 years
STANDARD_DEVIATION 1.8
22.1 years
STANDARD_DEVIATION 1.3
23.5 years
STANDARD_DEVIATION 1.7
22.9 years
STANDARD_DEVIATION 1.3
22.9 years
STANDARD_DEVIATION 1.6
Race/Ethnicity, Customized
Asian
0 Participants3 Participants2 Participants5 Participants10 Participants
Race/Ethnicity, Customized
Hispanic
4 Participants3 Participants7 Participants3 Participants17 Participants
Race/Ethnicity, Customized
More than one race
1 Participants1 Participants1 Participants1 Participants4 Participants
Race/Ethnicity, Customized
Nonhispanic White
10 Participants6 Participants3 Participants4 Participants23 Participants
Sex: Female, Male
Female
11 Participants8 Participants9 Participants7 Participants35 Participants
Sex: Female, Male
Male
4 Participants5 Participants4 Participants6 Participants19 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
EG007
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 130 / 130 / 130 / 130 / 130 / 150 / 13
other
Total, other adverse events
0 / 150 / 130 / 130 / 130 / 130 / 130 / 150 / 13
serious
Total, serious adverse events
0 / 150 / 130 / 130 / 130 / 130 / 130 / 150 / 13

Outcome results

Primary

Change in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)

Neural responses to emotional stimuli during the alcohol and placebo sessions were modeled. Fisher transformed correlation coefficients between regions of interest while viewing emotional stimuli (compared to squares) were calculated for each beverage session and data extracted for posthoc analysis. Values represent change scores in correlation coefficients during each beverage session.

Time frame: up to 1 week

Population: Analysis was completed prior to study completion.

ArmMeasureGroupValue (MEAN)Dispersion
BD Alcohol First, Then PlaceboChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Insula:sgACC functional connectivity: alcohol-0.04 Change scores in correlation coefficientStandard Error 0.02
BD Alcohol First, Then PlaceboChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Insula:sgACC functional connectivity: placebo0.001 Change scores in correlation coefficientStandard Error 0.02
BD Alcohol First, Then PlaceboChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Left NAc:vmPFC functional connectivity: alcohol-0.006 Change scores in correlation coefficientStandard Error 0.03
BD Alcohol First, Then PlaceboChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Left NAc:vmPFC functional connectivity: placebo-0.06 Change scores in correlation coefficientStandard Error 0.02
TD Alcohol First, Then PlaceboChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Insula:sgACC functional connectivity: placebo-0.0003 Change scores in correlation coefficientStandard Error 0.02
TD Alcohol First, Then PlaceboChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Left NAc:vmPFC functional connectivity: alcohol-0.05 Change scores in correlation coefficientStandard Error 0.02
TD Alcohol First, Then PlaceboChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Left NAc:vmPFC functional connectivity: placebo-0.002 Change scores in correlation coefficientStandard Error 0.02
TD Alcohol First, Then PlaceboChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Insula:sgACC functional connectivity: alcohol0.03 Change scores in correlation coefficientStandard Error 0.02
BD Placebo First, Then AlcoholChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Left NAc:vmPFC functional connectivity: alcohol0.01 Change scores in correlation coefficientStandard Error 0.02
BD Placebo First, Then AlcoholChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Insula:sgACC functional connectivity: placebo0.05 Change scores in correlation coefficientStandard Error 0.01
BD Placebo First, Then AlcoholChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Left NAc:vmPFC functional connectivity: placebo-0.014 Change scores in correlation coefficientStandard Error 0.03
BD Placebo First, Then AlcoholChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Insula:sgACC functional connectivity: alcohol0.002 Change scores in correlation coefficientStandard Error 0.02
TD Placebo First, Then AlcoholChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Left NAc:vmPFC functional connectivity: placebo0.003 Change scores in correlation coefficientStandard Error 0.02
TD Placebo First, Then AlcoholChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Insula:sgACC functional connectivity: placebo-0.006 Change scores in correlation coefficientStandard Error 0.02
TD Placebo First, Then AlcoholChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Insula:sgACC functional connectivity: alcohol0.05 Change scores in correlation coefficientStandard Error 0.03
TD Placebo First, Then AlcoholChange in Functional Coupling Between Regions of Interest During Viewing of Emotional Stimuli (Neural Responses While Viewing Emotional Stimuli Were Contrasted Against Neural Responses When Viewing Squares)Left NAc:vmPFC functional connectivity: alcohol-0.02 Change scores in correlation coefficientStandard Error 0.03
Comparison: Power analysis suggests this sample size (n = 23 with bipolar disorder, n = 24 healthy comparison participants), at an alpha = 0.05, provides \> 80% statistical power to detect a within subject effect size (ES) d ≥ 0.6 in both subgroups and a between group ES d ≥ 0.8 in this fMRI analysis.p-value: <0.004Mixed Models Analysis
Primary

Level of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)

Participants fill out self-report surveys \[specifically the Subjective Effects of Alcohol Scale (SEAS)\] on how they feel when they arrive to their beverage administration sessions (alcohol and placebo sessions). They then feel out the same self-report surveys on how intoxicated they feel during their beverage sessions (alcohol and placebo). Changes in how intoxicated they feel is calculated for both the alcohol and placebo condition (compared to how they felt pre-beverage). 4 subscores are calculated by summing individual items: positive valence/positive arousal (stimulation), SEAS positive valence/negative arousal (anxiolytic), negative valence/negative arousal (aggression/agitation), and negative valence/negative arousal (sedative effects). Summed subscores on the SEAS range between 0 and 40. Change scores can therefore range between -40 and 40 (post-beverage compared to pre-beverage feelings). Scores greater than 0 on any one subscale indicates feeling more effects of alcohol.

Time frame: up to 1 week

Population: Excluded participants with placebo manipulation issues. One TD participant was excluded because they later revealed a past depressive episode.

ArmMeasureGroupValue (MEAN)Dispersion
BD Alcohol First, Then PlaceboLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/positive arousal: alcohol session7.3 score on a scaleStandard Error 1.2
BD Alcohol First, Then PlaceboLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/positive arousal: placebo session4.1 score on a scaleStandard Error 1.1
BD Alcohol First, Then PlaceboLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/negative arousal: alcohol session-1.4 score on a scaleStandard Error 1.6
BD Alcohol First, Then PlaceboLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/negative arousal: placebo session1.7 score on a scaleStandard Error 0.98
TD Alcohol First, Then PlaceboLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/positive arousal: placebo session2.3 score on a scaleStandard Error 0.98
TD Alcohol First, Then PlaceboLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/negative arousal: alcohol session-5.3 score on a scaleStandard Error 0.9
TD Alcohol First, Then PlaceboLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/negative arousal: placebo session-0.42 score on a scaleStandard Error 0.47
TD Alcohol First, Then PlaceboLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/positive arousal: alcohol session3.6 score on a scaleStandard Error 1
BD Placebo First, Then AlcoholLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/negative arousal: alcohol session7.1 score on a scaleStandard Error 2.1
BD Placebo First, Then AlcoholLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/positive arousal: placebo session5.3 score on a scaleStandard Error 1.8
BD Placebo First, Then AlcoholLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/negative arousal: placebo session-2.3 score on a scaleStandard Error 0.97
BD Placebo First, Then AlcoholLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/positive arousal: alcohol session15.4 score on a scaleStandard Error 2.3
TD Placebo First, Then AlcoholLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/negative arousal: placebo session-2.96 score on a scaleStandard Error 4.7
TD Placebo First, Then AlcoholLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/positive arousal: placebo session3.3 score on a scaleStandard Error 1.1
TD Placebo First, Then AlcoholLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/positive arousal: alcohol session6.3 score on a scaleStandard Error 1.3
TD Placebo First, Then AlcoholLevel of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to Drinking)SEAS positive valence/negative arousal: alcohol session0.9 score on a scaleStandard Error 1.4
p-value: <0.05Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026